title: Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking.
abstract: Stressful life events are important contributors to relapse in recovering cocaine addicts, but the mechanisms by which they influence motivational systems are poorly understood. Studies suggest that stress may "set the stage" for relapse by increasing the sensitivity of brain reward circuits to drug-associated stimuli. We examined the effects of stress and corticosterone on behavioral and neurochemical responses of rats to a cocaine prime after cocaine self-administration and extinction. Exposure of rats to acute electric footshock stress did not by itself reinstate drug-seeking behavior but potentiated reinstatement in response to a subthreshold dose of cocaine. This effect of stress was not observed in adrenalectomized animals, and was reproduced in nonstressed animals by administration of corticosterone at a dose that reproduced stress-induced plasma levels. Pretreatment with the glucocorticoid receptor antagonist RU38486 did not block the corticosterone effect. Corticosterone potentiated cocaine-induced increases in extracellular dopamine in the nucleus accumbens (NAc), and pharmacological blockade of NAc dopamine receptors blocked corticosterone-induced potentiation of reinstatement. Intra-accumbens administration of corticosterone reproduced the behavioral effects of stress and systemic corticosterone. Corticosterone treatment acutely decreased NAc dopamine clearance measured by fast-scan cyclic voltammetry, suggesting that inhibition of uptake₂-mediated dopamine clearance may underlie corticosterone effects. Consistent with this hypothesis, intra-accumbens administration of the uptake₂ inhibitor normetanephrine potentiated cocaine-induced reinstatement. Expression of organic cation transporter 3, a corticosterone-sensitive uptake₂ transporter, was detected on NAc neurons. These findings reveal a novel mechanism by which stress hormones can rapidly regulate dopamine signaling and contribute to the impact of stress on drug intake.
authors.affiliation: Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201-1881, USA.
authors.forename: Evan N
authors.initials: EN
authors.lastname: Graf
authors.forename: Robert A
authors.initials: RA
authors.lastname: Wheeler
authors.forename: David A
authors.initials: DA
authors.lastname: Baker
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Ebben
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Hill
authors.forename: Jayme R
authors.initials: JR
authors.lastname: McReynolds
authors.forename: Mykel A
authors.initials: MA
authors.lastname: Robble
authors.forename: Oliver
authors.initials: O
authors.lastname: Vranjkovic
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Wheeler
authors.forename: John R
authors.initials: JR
authors.lastname: Mantsch
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Gasser
mesh_terms: D000315:Adrenalectomy; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects; D003345:Corticosterone / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D058999:Drug-Seeking Behavior / Q000187:drug effects* / Q000502:physiology; D004597:Electroshock; D005108:Extinction, Psychological / Q000187:drug effects / Q000502:physiology; D006727:Hormone Antagonists / Q000494:pharmacology; D008297:Male; D015735:Mifepristone / Q000494:pharmacology; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors; D012646:Self Administration; D015398:Signal Transduction / Q000187:drug effects; D013312:Stress, Physiological / Q000502:physiology
chemical_list: D018765:Dopamine Uptake Inhibitors; D006727:Hormone Antagonists; D011965:Receptors, Glucocorticoid; D015735:Mifepristone; D003042:Cocaine; D004298:Dopamine; D003345:Corticosterone